These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9522441)

  • 1. Metabolism of a novel CCK-B antagonist in rat, dog and human liver microsomes.
    Kajbaf M; Rossato P; Barnaby JR; Pellegatti M
    Xenobiotica; 1998 Feb; 28(2):167-78. PubMed ID: 9522441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo metabolism of a novel cholecystokinin B (CCK-B) antagonist in rat and dog plasma and rat faeces.
    Kajbaf M; Marchioro C; Barnaby JR; Pellegatti M
    Xenobiotica; 1998 Aug; 28(8):785-94. PubMed ID: 9741957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro metabolism of GV150013X by using liver microsomes and liver tissue slices from different species.
    Kajbaf M; Rossato P; Ferrari L; Grossi P; Pellegatti M
    Eur J Drug Metab Pharmacokinet; 1997; 22(4):359-66. PubMed ID: 9512935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist.
    Semple G; Ryder H; Rooker DP; Batt AR; Kendrick DA; Szelke M; Ohta M; Satoh M; Nishida A; Akuzawa S; Miyata K
    J Med Chem; 1997 Jan; 40(3):331-41. PubMed ID: 9022799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
    Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
    Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of cholecystokinin tetrapeptide amide metabolites in liver microsomes of human, Rhesus Monkey, Sprague-Dawley rat and CD1 mouse using ultra-high performance liquid chromatography coupled to high resolution mass spectrometer.
    Kong L; Berg FJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Oct; 1096():80-87. PubMed ID: 30149298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of the new anxiolytic agent, a pyrido[1,2-]benzimidazole (PBI) analog (RWJ-53050), in rat and human hepatic S9 fractions, and in dog; identification of cytochrome p450 isoforms mediated in the human microsomal metabolism.
    Wu WN; McKown LA; Reitz AB
    Eur J Drug Metab Pharmacokinet; 2006; 31(4):277-83. PubMed ID: 17315539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo.
    Takinami Y; Yuki H; Nishida A; Akuzawa S; Uchida A; Takemoto Y; Ohta M; Satoh M; Semple G; Miyata K
    Aliment Pharmacol Ther; 1997 Feb; 11(1):113-20. PubMed ID: 9042983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of in vitro metabolites of TM-2, a potential antitumor drug, in rat, dog and human liver microsomes using liquid chromatography/tandem mass spectrometry.
    Men L; Zhao Y; Lin H; Yang M; Liu H; Tang X; Yu Z
    Rapid Commun Mass Spectrom; 2014 Oct; 28(20):2162-70. PubMed ID: 25178720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cholecystokinin peptides and GV 150013, a selective cholecystokininB receptor antagonist, on electrically evoked endogenous GABA release from rat cortical slices.
    Ferraro L; Beani L; Trist D; Reggiani A; Bianchi C
    J Neurochem; 1999 Nov; 73(5):1973-81. PubMed ID: 10537055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl-1H-1,4- benzodiazepin-3-yl]-3-(3-methylphenyl)urea]: an irreversible cholecystokinin type-B receptor antagonist.
    Dunlop J; Brammer N; Evans N; Ennis C
    Biochem Pharmacol; 1997 Jul; 54(1):81-5. PubMed ID: 9296353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of in vivo and in vitro metabolites of 4,5-dimethoxycanthin-6-one by HPLC-Q-TOF-MS/MS.
    Miao X; Wang J; Chen L; Peng Z; Chen Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 May; 1020():78-84. PubMed ID: 27030894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.
    Patel S; Smith AJ; Chapman KL; Fletcher AE; Kemp JA; Marshall GR; Hargreaves RJ; Ryecroft W; Iversen LL; Iversen SD
    Mol Pharmacol; 1994 Nov; 46(5):943-8. PubMed ID: 7969084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro metabolism study of combretastatin A-4 in rat and human liver microsomes.
    Aprile S; Del Grosso E; Tron GC; Grosa G
    Drug Metab Dispos; 2007 Dec; 35(12):2252-61. PubMed ID: 17890446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro studies on the oxidative metabolism of 20(s)-ginsenoside Rh2 in human, monkey, dog, rat, and mouse liver microsomes, and human liver s9.
    Li L; Chen X; Zhou J; Zhong D
    Drug Metab Dispos; 2012 Oct; 40(10):2041-53. PubMed ID: 22829543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of vesatolimod in rat, dog, and human liver microsomes: Metabolic stability assessment, metabolite identification, and interspecies comparison.
    Li W; Zhang J; Wang Y; Hu F; Zhang Y
    Drug Test Anal; 2019 Feb; 11(2):240-249. PubMed ID: 30129284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liver microsomes.
    Gandhi AS; Wohlfarth A; Zhu M; Pang S; Castaneto M; Scheidweiler KB; Huestis MA
    Drug Test Anal; 2015 Mar; 7(3):187-98. PubMed ID: 24827428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
    Nishida A; Miyata K; Tsutsumi R; Yuki H; Akuzawa S; Kobayashi A; Kamato T; Ito H; Yamano M; Katuyama Y
    J Pharmacol Exp Ther; 1994 May; 269(2):725-31. PubMed ID: 7910212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro metabolism of l-corydalmine, a potent analgesic drug, in human, cynomolgus monkey, beagle dog, rat and mouse liver microsomes.
    Tang X; Di X; Zhong Z; Xie Q; Chen Y; Wang F; Ling Z; Xu P; Zhao K; Wang Z; Liu L; Liu X
    J Pharm Biomed Anal; 2016 Sep; 128():98-105. PubMed ID: 27239758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotransformation of 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878), a novel 5-hydroxytryptamine (5-HT)1A agonist/5-HT3 antagonist, in human hepatic cytochrome P450 enzymes.
    Minato K; Suzuki R; Asagarasu A; Matsui T; Sato M
    Drug Metab Dispos; 2008 May; 36(5):831-40. PubMed ID: 18238859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.